Importance of β2 adrenergic receptor genotype, gender and race on albuterol-evoked bronchodilation in asthmatics

Pulmonary Pharmacology and Therapeutics

Volumn 13, Issue 3, 2000, Pages 127-134

  Lima, John J ^a   Mohamed, Mohamad H N ^a   Self, Timothy H ^a   Eberle, Louis V ^a   Johnson, Julie A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Albuterol; FEV1; Gender; Genotype; Race

Indexed keywords

ARGININE; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; GLYCINE; SALBUTAMOL; TRIAMCINOLONE;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CAUCASIAN; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HOMOZYGOTE; HUMAN; HYSTERESIS; MALE; NEGRO; PHARMACODYNAMICS; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE;

EID: 0033769640     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2000.0239     Document Type: Article

References (29)

1. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma
2. Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: Data from the second National Health and Nutrition Examination Survey, 1976-1980 (NHANES JI)
3. Respiratory diseases disproportionately affecting minorities
4. US asthma mortality: 1941-1989
5. Stabilization of asthma mortality
6. Observations on the effects of aerosolized albuterol in acute asthma
7. Racial differences in lymphocyte beta-receptor sensitivity to propranolol
8. Racial differences in beta-adrenoceptor-mediated responsiveness
9. Attenuation of isoproterenol-mediated vasodilatation in blacks
10. Reduced beta 2-receptor mediated vasodilation in African Americans
11. Characteristics of patients with asthma within a large HMO: A comparison by age and gender
12. Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: A prospective study based on a sample of the general population. Copenhagen City Heart Study Group
13. Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline
14. Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle
15. The effects of the menstrual cycle, race, and gender on adrenergic receptors and agonists
16. Effects of gender and race on albuterol pharmacokinetics
17. 2-adrenergic receptor on albuterol bronchodilator pharmacodynamics
18. Standardization of Spirometry, 1994. American Thoracic Society
19. Influence of airway geometry on expiratory flow limitation and density dependence
20. The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families
21. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine
22. Physiologic indirect response models characterize diverse types of pharmacodynamic effects
23. Pharmacodynamic concepts
24. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties
25. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells
26. Terbutaline-induced desensitization of human lymphocyte beta 2- adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen
27. Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression
28. Distribution of genetic polymorphisms of β2-adrenoceptor gene between black and white populations